Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384604 · ClinicalTrials.gov registry record
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 1,189
- Enrollment target
NCT01384604 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,189 participants.
The verdict
NCT01384604 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 1,189 participants
- Enrollment target
Study Summary
The overall goal of this project is to identify intermediate phenotypes for psychosis across the schizophrenia and bipolar disorders boundary with implications for future genetic studies. Recent studies provide considerable evidence that schizophrenia and psychotic bipolar disorder may share overlapping etiologic determinants. Identifying disease-related genetic effects is a major focus in schizophrenia and bipolar research, with enormous implications for diagnosis and treatment for these two disorders. Efforts have been multifaceted, with the ultimate goal of describing causal paths from specific genetic variants, to changes in neuronal functioning, to altered brain anatomy, to behavioral and functional impairments. Parallel efforts have identified and refined several alternative endophenotypes that are stable, heritable, have (partly) known biological substrates, and are associated with psychosis liability. Although many such endophenotypes have been individually studied in schizophrenia, and to a lesser extent in bipolar disorder, no study has comprehensively assessed a broad panel of these markers in the two disorders with parallel recruitment, and the extent to which they mark independent aspects of psychosis risk, or their overlap in the two disorders. In this research project, we will examine a broad panel of putative endophenotypes in affected individuals and their first degree, biological relatives in order to: 1) characterize the degree of familial phenotypic overlap between schizophrenia and psychotic bipolar disorders; 2) identify patterns of endophenotypes unique to the two disorders; and, 3) contrast the heritability of endophenotypes across the disorders. We will obtain measures of neurophysiology (e.g., eye tracking, P50 gating, PPI, and P300), neurocognition (e.g., attention/vigilance, episodic and working memory), and brain structure (e.g., volumes of gray and white matter in specified brain regions). Blood samples will also be collected and stored
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,189 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01384604
The ClinicalTrials.gov registry entry for NCT01384604 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01384604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01384604 about?
NCT01384604 is a clinical study titled "Neurophysiological Studies in Schizophrenia and Psychiatric Disorders". The overall goal of this project is to identify intermediate phenotypes for psychosis across the schizophrenia and bipolar disorders boundary with implications for future genetic studies. Recent studies provide considerable evidence that schizophrenia and psychotic bipolar disorder may share overlap...
What is the current status of trial NCT01384604?
This trial is currently completed. The enrollment target is 1,189 participants. The study started on 2007-12. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01384604?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.